Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and ...

The RNA Targeting Small Molecule Drug Discovery Market is poised for growth, driven by demand for treatments targeting cancer ...

Machine learning and supercomputing have brought about a revolution in computational drug discovery. More therapeutic ...

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ ...

Proteins represent 95% of drug targets designed to combat disease, according to Yvonne Tan, PhD, from Nuclera.

According to brokerage Jefferies, the average drug development cycle spans 8 to 10 years, with success rates below 10% and ...

Selvita is the first contract research organisation (CRO) to license a Chemical Protein Stability Assay developed and ...

Drug discovery, and science in general, are fields built on data. Foundation models bring new capabilities by integrating ...

Study suggests gasdermin D inhibition may protect mice by blocking release of cellular contents into the extracellular ...

Collaboration combines Nuclera’s eProtein Discovery System with Cytiva’s Biacore SPR system.

The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated the global drug discovery services market size at USD 18.5 billion in 2022. During the forecast ...